Summary: A mechanism that links exposure to high-fat diets in mice to changes in hypothalamic function which leads to depression has been identified. Saturated fatty acids enter the brain via the bloodstream, where they accumulate and affect key signaling pathways associated with the development of depression. Source: University of Glasgow Obesity and depression have long been linked, with previous clinical studies finding an association between these two conditions. However, until now, the mechanisms of how obesity affects depression and vice versa have not been fully understood. Now, in a new study led by the University of Glasgow in collaboration with the Gladstone Institutes, and published today in Translational Psychiatry, scientists have been able to demonstrate the links between the consumption of diets high in saturated fats that lead to obesity and the development of depression phenotypes. They have also found that by decreasing the expression of a specific enzyme called phosphodiesterase, symptoms of obesity-linked depression can be reduced. In novel findings, shown in mouse models, researchers were able to see that saturated fatty acids were actually entering the brain via the bloodstream and thereafter accumulate and affect crucial brain signals related to depression. Mice fed a fat-dense diet (made up of 60% saturated and unsaturated fats) were shown to have an influx of dietary fatty acids in the hypothalamus region of the brain, an area related to the metabolic system and known to be linked with depression. These fatty acids were then able to directly affect the key signaling pathways responsible for the development of depression. The relationship between obesity and depression is known to be complicated, with patients with obesity less likely to respond well to common antidepressant medication. Indeed, patients with obesity show a substantially slower response to antidepressant treatment, with less overall improvements. Researchers in this study believe that their novel findings may now influence new targets for antidepressant medications that may be more suitable for overweight and obese individuals. Professor George Baillie, the lead author of the study from the University of Glasgow, said: “This is the first time anyone has observed the direct effects a high-fat diet can have on the signaling areas of the brain related to depression. This research may begin to explain how and why obesity is linked with depression and how we can potentially better treat patients with these conditions. “We often use fatty food to comfort ourselves as it tastes really good, however in the long term, this is likely to affect one’s mood in a negative way. Of course, if you are feeling low, then to make yourself feel better you might treat yourself to more fatty foods, which then would consolidate negative feelings. The relationship between obesity and depression is known to be complicated, with patients with obesity less likely to respond well to common antidepressant medication. The image is adapted from the University of Glasgow news release. “We all know that a reduction in fatty food intake can lead to many health benefits, but our research suggests that it also promotes a happier disposition. Further to that, understanding the types of fats, such as palmitic acid, which are likely to enter the brain and affect key regions and signaling will give people more information about how their diet can potentially affect their mental health.” In this study, researchers found that either dietary or genetically induced obesity in mice leads to depression phenotype and that this phenomenon occurred via the disruption of the cAMP/PKA signalling pathway. In addition, they found that the consumption of a fat-dense diet led to an influx of dietary fatty acids specifically in the hypothalamus. These fatty acids could then directly modulate the PKA signalling pathway responsible for the development of depression. These findings suggest that the influx of saturated fatty acids due to the consumption of a high-fat diet can alter the cAMP/PKA signalling process, which results in the development of depression phenotype. Funding: The work was funded by the Medical Research Council (MRC) and Onassis Foundation Predoctoral Fellowship. [divider]About this neuroscience research article[/divider]See alsoFeaturedNeuroscience·April 22, 2020Bilingualism does not make you ‘smarter’ Source: University of Glasgow Media Contacts: George Baillie – University of Glasgow Image Source: The image is adapted from the University of Glasgow news release. Original Research: Open access “A high-fat diet promotes depression-like behaviour in mice by suppressing hypothalamic PKA signalling”. Eirini Vagena, Jae Kyu Ryu, Bernat Baeza-Raja, Nicola M. Walsh, Catriona Syme, Jonathan P. Day, Miles D. Houslay & George S. Baillie . Translational Psychiatry. doi:10.1038/s41398-019-0470-1 Abstract A high-fat diet promotes depression-like behaviour in mice by suppressing hypothalamic PKA signalling Obesity is associated with an increased risk of depression. The aim of the present study was to investigate whether obesity is a causative factor for the development of depression and what is the molecular pathway(s) that link these two disorders. Using lipidomic and transcriptomic methods, we identified a mechanism that links exposure to a high-fat diet (HFD) in mice with alterations in hypothalamic function that lead to depression. Consumption of an HFD selectively induced accumulation of palmitic acid in the hypothalamus, suppressed the 3′, 5′-cyclic AMP (cAMP)/protein kinase A (PKA) signaling pathway, and increased the concentration of free fatty acid receptor 1 (FFAR1). Deficiency of phosphodiesterase 4A (PDE4A), an enzyme that degrades cAMP and modulates stimulatory regulative G protein (Gs)-coupled G protein-coupled receptor signaling, protected animals either from genetic- or dietary-induced depression phenotype. These findings suggest that dietary intake of saturated fats disrupts hypothalamic functions by suppressing cAMP/PKA signaling through activation of PDE4A. FFAR1 inhibition and/or an increase of cAMP signaling in the hypothalamus could offer potential therapeutic targets to counteract the effects of dietary or genetically induced obesity on depression. [divider]Feel free to share this Neuroscience News.[/divider] Join our Newsletter I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information ) Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.comWe hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.